Pulmonary Hypertension Association home
Pulmonary Hypertension Association
 contact us | join PHA | site map/search

Medical Journal

 

Choice of Venous Access Sites
Commonly, the right internal jugular vein is used for insertion of a venous sheath through which the pulmonary artery catheter is passed. Other sites can be advantageous, depend-ing on the situation (Table 1). For a patient’s initial catheteri-zation, use of the femoral veins for catheterization may be preferred, because it allows the greatest flexibility with which the clinician can perform the most thorough evaluation. This is especially important for excluding left heart pathology when direct measuremebnt of left ventricular end diastolic pressure is necessary.

Table—Common Venous Access Sites
Site   Advantages   Disadvantages   Complications
Right internal jugular vein   Facilitates pulmonary artery access; proximity to heart; may not need fluoroscopy   Cutaneous access can be difficult   Hematoma, pneumothorax,
tracheal obstruction
Left subclavian vein   Facilitates pulmonary artery access; proximity to heart   Vascular control of bleeding difficult   Pneumothorax, hemothorax
Femoral veins   Easiest to cannulate; easiest for vascular control of bleeding   Most problematic for pulmonary artery access; small
risk of infection; limits patient
mobility; fluoroscopy required
  Hematoma

Measurements to Record
Standard right-heart catheterization measurements (Figure 3) include:

  • right atrial pressure (RAP)
  • right ventricular pressure (RVP)
  • pulmonary arterial pressure (PAP)
  • pulmonary capillary wedge pressure (PCWP)
  • systemic arterial pressure (BP) and heart rate
  • cardiac output (CO)
  • pulmonary arterial vasoreactivity
  • pulmonary arterial (PA) (“mixed venous”) saturation
  • superior vena cava (SVC) saturation*
  • inferior vena cava (IVC) saturation* • right atrial (RA) saturation*
  • right ventricular (RV) saturation*

 

*When indicated.

Normal pressure waveforms are shown in Figure 3. PCW pressure measurements are made when the balloon of the catheter is inflated after the catheter has been properly advanced into the pulmonary artery. The inflated balloon prevents the  measurement of any pressure proximal to the balloon, and thus measurements recorded from the tip of the catheter reflect only left atrial pressure, which is commonly used as a surrogate for left ventricular end diastolic pressure.

The PCW pressure tracing should display three waveforms: the awave represents contraction of the left atrium. The cwave is due to a rapid rise in the left ventricular pressure in early systole, causing the mitral valve to bulge backward into the left atrium, so that the atrial pressure increases momen-tarily. The vwave is produced when blood enters the left atrium during late systole, the time at which most filling of the left atrium occurs.

Hemodynamic calculations– The following formulas are used to calculate standard hemodynamic parameters derived from the above measurements:

Mean* systemic arterial pressure (mBP) =
diastolic BP + (systolic-diastolic BP)/3

Mean* pulmonary arterial pressure (mPAP) =
diastolic PAP + (systolic-diastolic PAP)/3

Pulmonary vascular resistance (PVR) =
(mPAP-PCW pressure)/Cardiac output (CO)

Pulmonary vascular resistance index (PVRI) =
PVR/Body surface area (BSA)

Systemic vascular resistance (SVR) = (mBP-RAP)/CO

Systemic vascular resistance index (SVRI) = SVR/BSA

*Mean values may be more readily obtained by taking readings from bedside electronic monitoring equipment, which obviates the need for adjusting arithmetic means for extreme heart rates.

Cardiac output measurements– There are two standard methods for determining cardiac output. Both methods meas-ure pulmonary blood flow, which in the absence of an intra-cardiac shunt is equal to systemic blood flow.

The thermodilution method for determining cardiac output uses the indicator dilution principle, where the indicator is cold saline infused as a bolus injection into the proximal port of the right-heart catheter. The thermistor at the distal end of the catheter then measures the appearance and disappear-ance of indicator over time, and a cardiac output is then calculated. This method can be inaccurate at very high or very low cardiac outputs, and can underestimate cardiac output when significant valve regurgitation is present.

When using this technique, the clinician must ensure that the proximal right atrial port for injection is actually in the right atrium, since the port can be in the right ventricle when the catheter is wedged.

The Fick method for determining cardiac output is based on the principle that consumption of a substance (oxygen in this case) must equal blood flow to the organ multiplied by the difference between the arterial and venous concentrations of the substance. For this method, the formula for cardiac output is as follows:

CO =
oxygen consumption per minute (VO 2 )
(arterial oxygen content – venous oxygen content)

where oxygen content is calculated as: 1.34 x [Hb] x oxygen saturation/100.

In this case, the oxygen consumption can either be esti-mated or directly measured using standard techniques.6 Arterial oxygen saturation is usually determined by arterial blood gas analysis, while venous oxygen saturation is determined by mixed venous (pulmonary arterial) blood gas analysis.

Note: In order to measure systemic arterial oxygen saturation for determining cardiac output using the Fick method, caution should be exercised when relying on pulse oximetry, since both overestimation and underestimation can lead to significant errors in cardiac output calculations.7,8,9 Additionally, pulse oximetry may not be reliable in patients with Raynaud’s phenomenon, a common finding in patients with PAH.

Shunt measurements– An abnormally high pulmonary arterial saturation suggests a right-to-left shunt due to congen-ital heart disease and requires further evaluation and testing to identify and quantitate the shunt. Quantitation of left-to-right and/or right-to-left shunting is an integral part of right-heart catheterization.10 However, these calculations are beyond the scope of this article.

Left heart catheterization – Left-heart catheterization is not required in all patients with suspected PAH and should be reserved for patients for the following diagnostic purposes:

  • validation of abnormal PCW pressure/evaluation of left ventricular diastolic dysfunction
  • suspected left-sided valvular lesion (mitral, aortic)
  • suspected coronary artery disease

Some PAH specialists prefer to perform left-heart catheter-ization in all patients with suspected PAH as part of their initial (diagnostic) evaluation, to assure that the all-exclusive workup of PAH is complete.

back | Advances in PH home | Medical Section | PHA home

Email to a friend


Better Business Bureau Accredited Charity bbb.org/charity Charity Navigator 4 Star Charity Rating best in america seal


The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

Questions about the site? email web@PHAssociation.org

Pulmonary Hypertension Association
801 Roeder Road, Ste. 400
Silver Spring, MD 20910

Copyright © 2008 Pulmonary Hypertension Association
Read our privacy policy.

For optimal viewing of PHAssociation.org we recommend the following:

PC : Windows running Internet Explorer 5.5 or higher
Macintosh: Internet Explorer 5.2 or higher
free download from Microsoft.com

  Macromedia Flash Player
free download from Macromedia.com
  Adobe Acrobat Reader 6.0 or higher
free download from Adobe.com
Patients Medical Caregivers Media What is PH